$48.3 M

ATNM Mkt cap, 14-Dec-2018
Actinium Pharmaceuticals Net income (Q3, 2018)-6.1 M
Actinium Pharmaceuticals EBIT (Q3, 2018)-6.2 M
Actinium Pharmaceuticals Cash, 30-Sep-201814.8 M

Actinium Pharmaceuticals Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

R&D expense

12.3m

General and administrative expense

3.9m10.2m11.5m9.3m9.2m

Operating expense total

6.6m22.4m24.8m26.8m26.9m

EBIT

(6.6m)(22.5m)(24.8m)(26.8m)(26.9m)

Interest expense

2.5k866.07.9k5.0k

Interest income

5.4k

Net Income

(10.8m)(24.7m)(21.0m)(24.3m)(26.6m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

R&D expense

4.5m

General and administrative expense

830.7k1.7m2.4m3.3m3.8m3.6m1.8m2.2m2.8m1.4m3.3m2.8m1.7m1.9m1.6m2.0m

Operating expense total

1.6m4.1m4.4m7.0m7.9m7.4m4.6m6.0m6.9m7.1m7.8m7.2m6.7m6.4m4.9m6.2m

Depreciation and amortization

1.4k

EBIT

(1.6m)(4.1m)(4.4m)(7.0m)(7.9m)(7.4m)(4.6m)(6.0m)(6.9m)(7.1m)(7.8m)(7.2m)(6.7m)(6.4m)(4.9m)(6.2m)

Interest expense

1.3k5.7k1.6k588.02.7k1.7k666.0

Interest income

49.030.3k50.0k49.2k

Net Income

(1.4m)(16.7m)3.5m(6.1m)(3.1m)(7.5m)(3.9m)(4.4m)(6.6m)(6.6m)(8.1m)(7.1m)(6.3m)(6.3m)(4.9m)(6.1m)

Actinium Pharmaceuticals Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

5.5m6.7m25.6m20.5m17.4m

Accounts Receivable

2.1b

Inventories

218.4k699.9k803.5k1.8m

Current Assets

5.8m7.4m26.5m22.4m17.8m

PP&E

13.9k127.7k106.1k88.5k57.4k

Total Assets

5.8m7.6m26.6m22.5m18.3m

Accounts Payable

379.0k2.3m1.5m4.2m4.6m

Short-term debt

157.8k283.6k265.7k

Current Liabilities

7.3m9.5m4.6m4.5m4.7m

Long-term debt

157.8k283.6k265.7k

Total Debt

315.7k567.1k531.4k

Total Liabilities

7.3m4.6m4.5m4.7m

Additional Paid-in Capital

64.9m89.3m134.2m154.5m176.7m

Retained Earnings

(91.2m)(112.2m)(136.6m)(163.2m)

Total Equity

(1.6m)(1.9m)22.0m18.0m13.7m

Debt to Equity Ratio

-0.2 x-0.3 x0 x

Debt to Assets Ratio

0.1 x0.1 x0 x

Financial Leverage

-3.7 x-3.9 x1.2 x1.3 x1.3 x

Actinium Pharmaceuticals Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(10.8m)(24.7m)(21.0m)(24.3m)(26.6m)

Depreciation and Amortization

1.6k37.9k53.5k77.5k55.9k

Accounts Receivable

Inventories

106.6k(193.9k)162.1k(1.0m)

Accounts Payable

(518.1k)(793.9k)2.7m405.2k

Cash From Operating Activities

(6.3m)(14.3m)(18.5m)(20.8m)(21.6m)

Purchases of PP&E

(16.6k)(151.7k)(47.8k)(60.0k)(24.7k)

Cash From Investing Activities

(16.6k)(186.4k)(47.8k)(109.8k)(380.9k)

Cash From Financing Activities

6.2m15.7m37.5m15.8m18.8m

Interest Paid

561.0866.07.9k5.0k

Actinium Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.4 x
Report incorrect company information